HWG Holdings LP Invests $1.61 Million in Zoetis Inc (ZTS)
HWG Holdings LP bought a new position in shares of Zoetis Inc (NYSE:ZTS) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 17,537 shares of the company’s stock, valued at approximately $1,606,000.
Several other hedge funds have also recently bought and sold shares of ZTS. Valeo Financial Advisors LLC grew its stake in shares of Zoetis by 34.4% in the 2nd quarter. Valeo Financial Advisors LLC now owns 2,210 shares of the company’s stock worth $202,000 after buying an additional 566 shares during the last quarter. Dupont Capital Management Corp grew its stake in shares of Zoetis by 2.5% in the 2nd quarter. Dupont Capital Management Corp now owns 24,508 shares of the company’s stock worth $2,088,000 after buying an additional 601 shares during the last quarter. Dorsey Wright & Associates grew its stake in shares of Zoetis by 7.9% in the 2nd quarter. Dorsey Wright & Associates now owns 8,386 shares of the company’s stock worth $714,000 after buying an additional 617 shares during the last quarter. Rehmann Capital Advisory Group grew its stake in shares of Zoetis by 40.5% in the 2nd quarter. Rehmann Capital Advisory Group now owns 2,190 shares of the company’s stock worth $187,000 after buying an additional 631 shares during the last quarter. Finally, Wrapmanager Inc. grew its stake in shares of Zoetis by 7.9% in the 2nd quarter. Wrapmanager Inc. now owns 9,176 shares of the company’s stock worth $782,000 after buying an additional 672 shares during the last quarter. Hedge funds and other institutional investors own 89.76% of the company’s stock.
ZTS has been the topic of several recent research reports. Jefferies Financial Group set a $96.00 price target on Zoetis and gave the stock a “buy” rating in a research note on Friday, July 13th. Cantor Fitzgerald set a $98.00 price target on Zoetis and gave the stock a “buy” rating in a research note on Friday, July 27th. Bank of America upped their price objective on Zoetis from $97.00 to $100.00 and gave the company a “buy” rating in a research report on Monday, July 30th. BMO Capital Markets reaffirmed a “hold” rating and issued a $82.00 price objective on shares of Zoetis in a research report on Thursday, August 2nd. Finally, Morgan Stanley upped their price objective on Zoetis from $87.00 to $92.00 and gave the company a “hold” rating in a research report on Friday, August 3rd. Seven investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. The company currently has an average rating of “Buy” and an average target price of $92.63.
Zoetis (NYSE:ZTS) last released its quarterly earnings data on Thursday, August 2nd. The company reported $0.77 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.71 by $0.06. The business had revenue of $1.42 billion for the quarter, compared to analysts’ expectations of $1.38 billion. Zoetis had a return on equity of 72.30% and a net margin of 19.95%. The firm’s quarterly revenue was up 11.5% on a year-over-year basis. During the same period in the prior year, the firm posted $0.53 EPS. As a group, analysts forecast that Zoetis Inc will post 3.07 EPS for the current year.
The company also recently declared a quarterly dividend, which will be paid on Monday, December 3rd. Stockholders of record on Tuesday, November 20th will be issued a dividend of $0.126 per share. The ex-dividend date is Monday, November 19th. This represents a $0.50 annualized dividend and a dividend yield of 0.55%. Zoetis’s payout ratio is 20.83%.
In other news, insider Roxanne Lagano sold 2,000 shares of the stock in a transaction on Monday, October 1st. The stock was sold at an average price of $92.03, for a total transaction of $184,060.00. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, insider Kristin C. Peck sold 5,000 shares of the stock in a transaction on Wednesday, August 1st. The shares were sold at an average price of $86.22, for a total value of $431,100.00. The disclosure for this sale can be found here. Insiders have sold a total of 213,467 shares of company stock worth $19,502,725 over the last three months. Insiders own 0.35% of the company’s stock.
Zoetis Inc discovers, develops, manufactures, and markets veterinary vaccines and medicines in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses.
Featured Story: Investing strategies using the yield curve
Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc (NYSE:ZTS).
Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.